Get a Free Stock Report on Keryx Biopharmaceuticals Inc. (KERX) At VIPStockReports.com

Free stock reports are available direct from VIPStockReports.com. You can get a free stock report on any company right from VIPStockReports.com. Get up to date stock information right from VIPStockReports.com on Keryx Biopharmaceuticals Inc. (KERX) as well as other companies that you want to follow.

On Wednesday, August 14th, the stock opened at 8.98 which is up 0.01 from its previous close of 8.97. As of noon that day, the range had already risen to 9.02 and had gone as low as 8.81. In the past 52 weeks, the stock has gone up to 9.98, but went as low as 1.88. The volume was 356,872, while the Company’s average over the last three months has was 2,183,910. The market cap was 723.24 million.

There is  more information on VIPStockReports.com where there is a free stock report that you can see right on the site. With this report you can see where the stock currently sits and all information necessary to make a wise decision.

On Thursday, August 8th, the Company announced that it had submitted a New Drug Application for iron-based phosphate binder Zerenex. Even though this is the Company’s only drug, it demonstrated impressive results when treating elevated serum phosphate levels in patients with chronic kidney disease.

There is more information on VIPStockReports.com where there is a free stock report that you can see right on the site. With this report you can see where the stock currently sits and all information necessary to make a wise decision.

About VIPStockReports

VIPStockReports.com screens the markets looking for hot emerging Micro-cap and small cap stocks that look to run high. Once we find the next hot penny stock with monster upside potential we immediately email it to you in our detailed VIP Report so you can stay ahead of the bell.